APA (7th ed.) Citation

Bakker, C., Tasker, T., Liptrot, J., Hart, E. P., Klaassen, E. S., Prins, S., . . . Nathan, P. J. (2021). First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1‐receptor partial agonist for the treatment of dementias. British journal of clinical pharmacology, 87(7), 2945-2955. https://doi.org/10.1111/bcp.14710

Chicago Style (17th ed.) Citation

Bakker, Charlotte, et al. "First‐in‐man Study to Investigate Safety, Pharmacokinetics and Exploratory Pharmacodynamics of HTL0018318, a Novel M1‐receptor Partial Agonist for the Treatment of Dementias." British Journal of Clinical Pharmacology 87, no. 7 (2021): 2945-2955. https://doi.org/10.1111/bcp.14710.

MLA (9th ed.) Citation

Bakker, Charlotte, et al. "First‐in‐man Study to Investigate Safety, Pharmacokinetics and Exploratory Pharmacodynamics of HTL0018318, a Novel M1‐receptor Partial Agonist for the Treatment of Dementias." British Journal of Clinical Pharmacology, vol. 87, no. 7, 2021, pp. 2945-2955, https://doi.org/10.1111/bcp.14710.